Page 13 – Senator Rand Paul

Dr. Rand Paul to Force U.S. Senate Vote on War Powers Resolution Concerning U.S. Troops in Syria

Dec 7, 2023 | 2023, Armed Forces and National Security, Congress

WASHINGTON, D.C. – Today, as a continuation of his efforts to return war powers to Congress and end the American military presence in Syria, which needlessly puts our troops’ lives in danger and risks further escalation of conflict in the Middle East, U.S. Senator Rand Paul (R-KY) will force the U.S. Senate to vote on his War Powers Resolution (S.J. Res. 51). His resolution directs the president to remove all U.S. Armed Forces from hostilities in and affecting Syria within 30 days of its enactment. Dr. Paul’s resolution is currently co-sponsored by U.S. Senators Mike Lee (R-UT) and JD Vance (R-OH).

Sens. Paul, McConnell Urge Biden Administration to Protect American Jobs, Remove Retaliatory Tariffs on Bourbon and Spirits

Dec 5, 2023 | 2023, Foreign Trade and International Finance

WASHINGTON, D.C. – Today, U.S. Senator Rand Paul (R-KY) and Senate Republican Leader Mitch McConnell (R-KY) wrote a letter to the Biden Administration urging quick action to protect the millions of U.S. jobs that rely on American bourbon and spirits producers. Without urgent action, the European Union (EU) will implement a 50% tariff on American whiskey imports on January 1, 2024, and American wine and other distilled spirits imports could see sharp tariff increases by 2026.

Dr. Rand Paul Urges FDA to Rescind Overburdensome Proposed Rule on Laboratory Developed Tests

Dec 5, 2023 | 2023, Health

WASHINGTON, D.C. – Yesterday, U.S. Senator Rand Paul (R-KY) sent a letter to Dr. Robert Califf, Commissioner of Food and Drugs at the U.S. Food and Drug Administration (FDA) about the FDA’s recent proposed rule on Laboratory Developed Tests (LDTs). The proposed rule would inappropriately impose the FDA’s medical device regulatory framework on health care providers developing and performing LDTs as part of their professional practice. It would also cause unnecessary disruptions to patient care.

Dr. Rand Paul Introduces Legislation to Restore and Protect Americans’ Fourth Amendment Rights

Nov 30, 2023 | 2023, Civil Rights and Liberties

WASHINGTON, D.C. – Today, U.S. Senator Rand Paul (R-KY) introduced the Fourth Amendment Restoration and Protection Act. A bill to restore and protect the Fourth Amendment rights of all Americans while still protecting national security. The bill would ensure Americans cannot be subjected to government surveillance upon the order of the secretive Foreign Intelligence Surveillance Court (FISC) or Executive Order 12333. While national security requires the ability to gather intelligence on foreign threats, using those authorities to conduct warrantless spying on Americans is an impermissible violation of the rights guaranteed to us by the Fourth Amendment.

Dr. Rand Paul Joins Effort to Demand Answers Over Biden Administration’s Unprecedented Pause of Firearms Export Licenses

Nov 21, 2023 | 2023, Congress, Second Amendment

WASHINGTON, D.C. — Recently, U.S. Senator Rand Paul (R-KY) joined Senator Ted Budd (R-NC) and 44 other U.S. Senators in a letter to Secretary of Commerce Gina Raimondo raising questions over the decision announced last month by the Bureau of Industry and Security to pause for 90 days the issuance of export licenses for firearms, ammunition, and certain accessories to most overseas markets. This unprecedented move is the latest chapter in the Biden administration’s hostility towards America’s firearms industry.

Dr. Rand Paul Urges FDA to Update Animal Testing Guidance in Accordance with the FDA Modernization Act 2.0

Nov 20, 2023 | 2023, Congress, Health

WASHINGTON, D.C. – Recently, U.S. Senator Rand Paul (R-KY), led a bipartisan group of nine senators in sending a letter to the U.S. Food and Drug Administration (FDA) to ensure the FDA is updating its animal testing regulations following the enactment of the FDA Modernization Act 2.0 last year. The legislation ended an outdated FDA mandate that required investigational new drugs to be tested on animals in pre-clinical trials. The legislation did not ban animal testing, but it allowed drug sponsors to use modern alternative methods to demonstrate a drug’s safety and effectiveness where they were suitable.

ICYMI: Dr. Rand Paul Forces Senate Vote on Conservative Amendment Saving Taxpayers Billions

Nov 16, 2023 | 2023, Congress, Economics and Public Finance

WASHINGTON, D.C. – Last night, U.S. Senator Rand Paul (R-KY) forced the U.S. Senate to vote on his conservative amendment to the U.S. House of Representatives’ short-term spending bill that would have saved American taxpayers $50 billion over ten weeks.

Dr. Paul, Sen. Budd Send Letter to Sec. Austin Demanding that DoD Rescind Abortion Travel Policy

Nov 14, 2023 | 2023, Armed Forces and National Security, Civil Rights and Liberties

WASHINGTON, D.C. – Today, U.S. Senators Rand Paul (R-KY) and Ted Budd (R-NC), along with 25 other GOP Senators, sent a letter to Secretary of Defense Lloyd Austin denouncing the department’s policy of paying the travel expenses of those servicemembers and dependents seeking abortions.

Dr. Rand Paul Joins Bipartisan Letter Urging the U.S. to End Prosecution of Julian Assange

Nov 14, 2023 | 2023, Civil Rights and Liberties

WASHINGTON, D.C. – Recently, U.S. Senator Rand Paul (R-KY) and 15 other bipartisan Members of Congress sent a letter encouraging President Biden to end the extradition request currently pending against Australian publisher Julian Assange and halt all prosecutorial proceedings against him in an effort to preserve free speech and freedom of the press.

Dr. Rand Paul and Senator Richard Blumenthal Reintroduce the Temporary Family Visitation Act

Nov 9, 2023 | 2023, Immigration

WASHINGTON, D.C. – Yesterday, U.S. Senator Rand Paul (R-KY) and Senator Richard Blumenthal (D-CT) reintroduced the Temporary Family Visitation Act (TFVA) that would establish a new B-3 nonimmigrant category allowing U.S. citizens and permanent residents to petition for their family members for temporary visas.